Longevity Klotho Neuro moves to acquire Turn Bio assetsBy adminOctober 2, 20250 Longevity biotech seeks to broaden its therapeutic capabilities with cellular reprogramming and delivery technologies. Longevity-focused biotech Klotho Neurosciences revealed it…